Nattan Brooks

Nattan is a self-taught investor and follows the value investing approach to picking stocks. He possesses over 10 years of investment experience, an M.B.A. from Louisiana State University, and is also certified in Risk Management Assurance. Nattan is a Certified Internal Auditor, Data Miner, and author with a career broadly spanning over multiple business areas. He has exploited those observations and developed investment tactics within a fundamentally sound long-term investment strategy. He currently covers Earnings News category for our site.


Worthwhile Stock:- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV)

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) stock traded volume of 21183 shares during its last trading session as compared to its average volume of 9327 shares over the recent month. BVXV ended its day with the below stream along the move of -3.01% and closed at the price of $6.45 before opening at $6.62. It has total market capitalization is $43461000. 52 week range of the stock remained $ 4.6 –